1. Home
  2. LSTA vs BOWN Comparison

LSTA vs BOWN Comparison

Compare LSTA & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • BOWN
  • Stock Information
  • Founded
  • LSTA 1980
  • BOWN 2023
  • Country
  • LSTA United States
  • BOWN United States
  • Employees
  • LSTA N/A
  • BOWN N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • BOWN
  • Sector
  • LSTA Health Care
  • BOWN
  • Exchange
  • LSTA Nasdaq
  • BOWN Nasdaq
  • Market Cap
  • LSTA 24.1M
  • BOWN 28.5M
  • IPO Year
  • LSTA N/A
  • BOWN 2023
  • Fundamental
  • Price
  • LSTA $2.61
  • BOWN $10.09
  • Analyst Decision
  • LSTA Strong Buy
  • BOWN
  • Analyst Count
  • LSTA 1
  • BOWN 0
  • Target Price
  • LSTA $15.00
  • BOWN N/A
  • AVG Volume (30 Days)
  • LSTA 15.8K
  • BOWN 2.8K
  • Earning Date
  • LSTA 08-11-2025
  • BOWN 01-01-0001
  • Dividend Yield
  • LSTA N/A
  • BOWN N/A
  • EPS Growth
  • LSTA N/A
  • BOWN N/A
  • EPS
  • LSTA N/A
  • BOWN 0.32
  • Revenue
  • LSTA $1,000,000.00
  • BOWN N/A
  • Revenue This Year
  • LSTA N/A
  • BOWN N/A
  • Revenue Next Year
  • LSTA N/A
  • BOWN N/A
  • P/E Ratio
  • LSTA N/A
  • BOWN $31.24
  • Revenue Growth
  • LSTA N/A
  • BOWN N/A
  • 52 Week Low
  • LSTA $1.87
  • BOWN $2.71
  • 52 Week High
  • LSTA $4.20
  • BOWN $19.77
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 50.61
  • BOWN 48.14
  • Support Level
  • LSTA $2.36
  • BOWN $8.88
  • Resistance Level
  • LSTA $3.07
  • BOWN $10.20
  • Average True Range (ATR)
  • LSTA 0.23
  • BOWN 0.32
  • MACD
  • LSTA 0.02
  • BOWN -0.03
  • Stochastic Oscillator
  • LSTA 37.50
  • BOWN 68.63

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About BOWN Bowen Acquisition Corp

Bowen Acquisition Corp is a blank check company.

Share on Social Networks: